Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 19/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TBXAS1 | P24557 | 6/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vapiprost SCHEMBL9344105 | 1.00 | TBXA2R (1.00) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL8895507 | 1.00 | TBXA2R (1.00) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL9342604 | 1.00 | TBXA2R (1.00) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL28551 | 1.00 | TBXA2R (1.00) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL9342608 | 1.00 | TBXA2R (1.00) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL635146 | 0.99 | TBXA2R (0.98) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL635147 | 0.99 | TBXA2R (0.98) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL27984405 | 0.99 | TBXA2R (0.98) | TBXA2RMEN1KMT2ATBXAS1 | |
| Vapiprost SCHEMBL7833619 | 0.98 | TBXA2R (0.96) | TBXA2RMEN1KMT2ATBXAS1 | |
| SCHEMBL10489337 | 0.94 | TBXA2R (0.90) | TBXA2RMEN1KMT2ATBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5595 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| US-20250144079-A1 | METHODS OF INHIBITING TUMOR METASTASIS | VANDERBILT UNIVERSITY | 2025-05-08 | — | — | US | claimed |
| US-20240041839-A1 | METHODS OF INHIBITING TUMOR METASTASIS | VANDERBILT UNIVERSITY | 2024-02-08 | — | — | US | claimed |
| CN-117122687-A | Methods for inhibiting tumor metastasis | 凡德贝尔大学 | 2023-11-28 | — | — | CN | claimed |
| US-20230090578-A1 | METHODS OF INHIBITING TUMOR METASTASIS | VANDERBILT UNIVERSITY | 2023-03-23 | — | — | US | claimed |
| WO-2022136939-A1 | A METHOD FOR PREPARATION OF A DRUG ENCAPSULATED LIPOSOME IN AN ORGANIC SOLVENT EMULSION | ZARAD SAMARTH (IN) | 2022-06-30 | — | — | WO | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| US-11167065-B2 | Shellac and paclitaxel coated catheter balloons | EUROCOR TECH GMBH (DE) | 2021-11-09 | — | — | US | claimed |
| US-10772967-B2 | Enhanced anticancer agent | Alhamadsheh, Mamoun M. (US) | 2020-09-15 | — | — | US | claimed |
| US-5637113-A | Polymer film for wrapping a stent structure | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 1997-06-10 | — | — | US | claimed |
| EP-0756853-A1 | Composite metal and polymer locking stents for drug delivery | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 1997-02-05 | — | — | EP | claimed |
| EP-0716836-A1 | Polymer film for wrapping a stent structure | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 1996-06-19 | — | — | EP | claimed |
| WO-1996017606-A1 | USE OF INFLAMMATORY MODULATORS IN THE TREATMENT OF CHRONIC OR RECALCITRANT SKIN DAMAGE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-06-13 | — | — | WO | claimed |
| WO-1995001177-A1 | MEDICAMENTS CONTAINING VAPIPROST HYDROCHLORIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 1995-01-12 | — | — | WO | claimed |
| EP-0448274-A2 | Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for the treatment of ulcerative gastrointestinal conditions | E.R. SQUIBB & SONS, INC. (US) | 1991-09-25 | — | — | EP | claimed |
| US-4977163-A | Antiasthmatics; cardiovascular disorders | GLAXO GROUP LIMITED (GB) | 1990-12-11 | — | — | US | claimed |
| US-4968703-A | SYNERGISTIC MIXTURE OF THROMBOXANE A2 ANTAGONIST AND THROMBOXANE SYNTHETASE INHIBITOR | GLAXO GROUP LIMITED (GB) | 1990-11-06 | — | — | US | claimed |
| US-4968673-A | THERAPY, PROPHYLAXIS | GLAXO GROUP LIMITED (GB) | 1990-11-06 | — | — | US | claimed |
| EP-0069447-B1 | AMINOCYCLOPENTANOL ACIDS AND ESTERS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATION | GLAXO GROUP LIMITED (GB) | 1986-10-29 | — | — | EP | claimed |